The many different professional guidelines [1] that give advice about genetic testing in children have been extensively reviewed in other papers in this issue of the journal. Here we present a case report illustrating how the issue of genetic testing in children continues to present challenges to clinical teams in practice. The identifying details of the case have been altered to preserve the anonymity of the family involved. …
Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.